These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9811514)

  • 1. Virus assay methods: accuracy and validation.
    Darling AJ; Boose JA; Spaltro J
    Biologicals; 1998 Jun; 26(2):105-10. PubMed ID: 9811514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verification and validation of diagnostic laboratory tests in clinical virology.
    Rabenau HF; Kessler HH; Kortenbusch M; Steinhorst A; Raggam RB; Berger A
    J Clin Virol; 2007 Oct; 40(2):93-8. PubMed ID: 17766174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensuring quality of in vitro alternative test methods: Current practice.
    Rispin A; Stitzel K; Harbell J; Klausner M
    Regul Toxicol Pharmacol; 2006 Jul; 45(2):97-103. PubMed ID: 16644076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SQA opinion paper on global harmonization of the bioanalytical method validation guidances.
    Tudan C; Rogenthien S; Jones A
    Bioanalysis; 2010 Dec; 2(12):1921-5. PubMed ID: 21110735
    [No Abstract]   [Full Text] [Related]  

  • 6. Criteria for the choice of viruses in validation studies.
    Minor PD
    Dev Biol Stand; 1993; 81():215-9. PubMed ID: 8174805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contamination with PCR detectable virus in a virus isolation quality assurance panel.
    Gunson RN; Abraham E; Carman WF
    J Virol Methods; 2006 Oct; 137(1):150-1. PubMed ID: 16860403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioassays for the characterisation and control of therapeutic cytokines; determination of potency.
    Thorpe R; Wadhwa M; Page C; Mire-Sluis A
    Dev Biol Stand; 1999; 97():61-71. PubMed ID: 10463531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of assays for use with combination vaccines.
    Klein J; Capen R; Mancinelli R; Robinett R; Pietrobon PJ; Quinn J; Schofield T
    Biologicals; 1999 Mar; 27(1):35-41. PubMed ID: 10441401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control in diagnostic virology.
    Hart RJ
    Proc R Soc Med; 1975 Oct; 68(10):622-4. PubMed ID: 1208508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal quality control in virology: validation of immunoassays using a personal computer spreadsheet.
    Wright JD
    Br J Biomed Sci; 2000; 57(4):302-6. PubMed ID: 11204860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues of biological assays for viral vaccines.
    Lee CK
    Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of biological assays.
    Schofield T
    Dev Biol (Basel); 2002; 107():25-32. PubMed ID: 12079188
    [No Abstract]   [Full Text] [Related]  

  • 14. For the proposition: for the diagnosis of viral infections, commercial assays provide more reliable results than do in-house assays.
    Gammie AJ
    Rev Med Virol; 2008; 18(2):73-6. PubMed ID: 18306442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
    Rubin SA; Afzal MA; Powell CL; Bentley ML; Auda GR; Taffs RE; Carbone KM
    J Infect Dis; 2005 Apr; 191(7):1123-8. PubMed ID: 15747248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Against the proposition: for the diagnosis of viral infections, commercial assays provide more reliable results than do in-house assays.
    James V
    Rev Med Virol; 2008; 18(2):77-80. PubMed ID: 18306441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical validity of bioassays.
    Heath AB
    Dev Biol Stand; 1999; 97():151-6. PubMed ID: 10463540
    [No Abstract]   [Full Text] [Related]  

  • 18. Setting specifications for potency assays--basic principles.
    Mire-Sluis AR
    Dev Biol (Basel); 2002; 107():107-15. PubMed ID: 12079184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
    Biologicals; 1991 Jul; 19(3):247-51. PubMed ID: 1954007
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.